Celecoxib
- Product NDC
- 70934-026
- 11-digit product format
- 709340026
- Labeler code
- 70934
- Product ID
- 70934-026_d242f001-6c4c-afa4-e053-2a95a90a9716
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA204197
- Marketing category
- ANDA
- Marketing start
- 2019-10-09
- Marketing end
- 0000-00-00
- Substance
- CELECOXIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-026-14 | 70934002614 | 14 CAPSULE in 1 BOTTLE (70934-026-14) | 14 capsule | 2017-03-16 | 0000-00-00 | No | No | Current |
| 70934-026-30 | 70934002630 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-026-30) | 30 capsule | 2018-06-20 | 0000-00-00 | No | No | Current |